- Home
- MGYR vs ANVS Comparison
MGYR vs ANVS Comparison
Compare MGYR & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGYR | ANVS |
|---|---|---|
| Founded | 1922 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.2M | 111.3M |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MGYR | ANVS |
|---|---|---|
| Price | $17.98 | $3.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 4.6K | ★ 519.0K |
| Earning Date | 01-22-2026 | 11-12-2025 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | ★ 27.11 | N/A |
| EPS | ★ 1.56 | N/A |
| Revenue | ★ $35,207,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.53 | ★ N/A |
| Revenue Growth | ★ 11.78 | N/A |
| 52 Week Low | $13.52 | $1.11 |
| 52 Week High | $19.04 | $5.50 |
Technical Indicators
Market Signals| Indicator | MGYR | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 63.83 | 39.02 |
| Support Level | $17.38 | $3.26 |
| Resistance Level | $17.75 | $4.14 |
| Average True Range (ATR) | 0.18 | 0.26 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 51.61 | 13.16 |
Price Performance
Historical ComparisonAbout MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.